在状细胞疾病中,凝血,补充,铁和炎症的无形链
Joan D Beckman1, Erica M Sparkenbaugh2
1Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Current opinion in hematology
|July 18, 2023
概括
最近的研究强调了状细胞病 (SCD) 中的血栓炎症. 针对ADAMTS-13/VWF轴等途径和减少铁过载可以减轻血管闭塞事件和器官损伤.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 状细胞疾病 (SCD) 的特征是复杂的血栓炎症机制.
- 了解这些机制对于开发有效的治疗方法来预防器官损伤至关重要.
研究的目的:
- 审查SCD中血栓炎症的机理学研究的最新进展.
- 专注于新的途径,临床相关性和翻译潜力.
- 鼓励进一步研究管理SCD并发症的年轻和老年人群.
主要方法:
- 关于SCD中血栓炎症的最新机制研究的综述.
- 讨论新的途径,包括中性粒细胞,ADAMTS-13/VWF轴,氧化应激和凝血级联.
- 包括相关的临床试验和翻译潜力.
主要成果:
- ADAMTS-13/VWF轴的调节失调与血管封闭事件 (VOE) 有关.
- 减少铁过载可以改善红细胞和中性粒细胞的功能,减少VOE和炎症.
- 向HO-1/ROS和内在凝血因子XII显示了减轻SCD病理的潜力.
- 还讨论了补充级联和中性粒细胞外细胞陷.
结论:
- 对血栓炎路径的新见解为SCD提供了治疗点.
- 针对ADAMTS-13/VWF轴,铁过载和凝血因子的干预措施可以减少器官损伤.
- 需要进一步的研究来将这些发现转化为临床实践,以改善SCD患者的治疗结果.
更多相关视频
相关概念视频
Multiple Allele Traits
34.4K
The Concept of Multiple Allelism
34.4K
Complement System
2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Introduction to Hemostasis
8.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K
Coagulation
7.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.1K
Disorders of Hemostasis
999
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
999


